公司資料
Novan 股價、新聞與催化劑
- 股票代碼:
- NOVN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for NOVN.
公司概覽
業務概覽
Novan was a dermatology-focused biotechnology company built around nitric oxide-based therapies for skin conditions and related inflammatory indications. Its story was centered on a narrow clinical platform and the challenge of turning topical science into a durable commercial path.
所在地與產業分類
Novan was headquartered in the United States and listed on NASDAQ, with a profile tied to dermatology and specialty biotech. It belonged to the small-cap development universe rather than a diversified pharma category.
商業模式特徵
The business depended on clinical progress, regulatory milestones, and financing discipline more than on broad commercial diversification. Investors typically watched proof-of-concept data, development updates, and whether the company could advance a focused dermatology franchise.
生技產業定位
Novan occupied a legacy small-cap dermatology niche within biotech. Because it was highly dependent on a limited number of programs, the stock was always sensitive to execution, funding, and regulatory visibility.
未來催化劑
- Novan is also mostly a legacy / closeout story, with catalysts limited to any residual asset or corporate-resolution update. There is no active standalone growth story left.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。